RA also downregulates the expression level of p-EGFR, EGFR, and Blc-2 in OVCAR3 cells, suggesting that it has anticancer potential for the treatment of ovarian carcinoma, and the underlying mechanism may be related to inhibiting EGFR activation. Here, EGFR is linked to ovarian carcinoma.